0001225208-15-001415.txt : 20150115 0001225208-15-001415.hdr.sgml : 20150115 20150115155553 ACCESSION NUMBER: 0001225208-15-001415 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150115 FILED AS OF DATE: 20150115 DATE AS OF CHANGE: 20150115 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Merck & Co., Inc. CENTRAL INDEX KEY: 0000310158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221918501 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 BUSINESS PHONE: 908-740-4000 MAIL ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 FORMER COMPANY: FORMER CONFORMED NAME: Merck & Co. Inc. DATE OF NAME CHANGE: 20091103 FORMER COMPANY: FORMER CONFORMED NAME: SCHERING PLOUGH CORP DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schechter Adam H CENTRAL INDEX KEY: 0001376841 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-06571 FILM NUMBER: 15529998 MAIL ADDRESS: STREET 1: MERCK & CO INC, ONE MERCK DRIVE STREET 2: P O BOX 100 CITY: WHITEHOUSE STATION STATE: NJ ZIP: 08889-0100 4 1 doc4.xml X0306 4 2015-01-15 0000310158 Merck & Co., Inc. MRK 0001376841 Schechter Adam H 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 1 EVP & Pres-Global Human Health Common Stock 2015-01-15 4 M 0 50000.0000 44.1900 A 50000.0000 D Common Stock 2015-01-15 4 M 0 19200.0000 35.0900 A 69200.0000 D Common Stock 2015-01-15 4 M 0 5000.0000 34.4700 A 74200.0000 D Common Stock 2015-01-15 4 S 0 74200.0000 62.4828 D 0.0000 D Common Stock 70794.9747 I By Trust Stock Option (right to buy) 34.4700 2015-01-15 4 M 0 5000.0000 0.0000 D 2007-02-01 2016-01-31 Common Stock 5000.0000 0.0000 D Stock Option (right to buy) 44.1900 2015-01-15 4 M 0 50000.0000 0.0000 D 2008-03-02 2017-03-01 Common Stock 50000.0000 0.0000 D Stock Option (right to buy) 35.0900 2015-01-15 4 M 0 19200.0000 0.0000 D 2007-03-03 2016-03-02 Common Stock 19200.0000 0.0000 D The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.1200 to $62.9800, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. Holdings include shares acquired in dividend reinvestment transactions. The option became exercisable in equal installments on 2/1/2007, 2/1/2008 and 2/1/2009. The option became exercisable in equal installments on 3/2/2008, 3/2/2009 and 3/2/2010. The option became exercisable in equal installments on 3/3/2007, 3/3/2008 and 3/3/2009. Katie Fedosz as Attorney-in-Fact for Adam H. Schechter 2015-01-15